Cargando…

CD248 as a novel therapeutic target in pulmonary arterial hypertension

Pulmonary vascular remodeling is the most important pathological characteristic of pulmonary arterial hypertension (PAH). No effective treatment for PAH is currently available because the mechanism underlying vascular remodeling is not completely clear. CD248, also known as endosialin, is a transmem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Tao, Shao, Lei, Wang, Aimei, Liang, Rui, Lin, Yuhan, Wang, Guan, Zhao, Yan, Hu, Jing, Liu, Shuangyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507048/ https://www.ncbi.nlm.nih.gov/pubmed/32997414 http://dx.doi.org/10.1002/ctm2.175

Ejemplares similares

Retracted: CD248 as a novel therapeutic target in pulmonary arterial hypertension
Publicado: (2021)

Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2016)

CD248: A therapeutic target in cancer and fibrotic diseases
por: Teicher, Beverly A.
Publicado: (2019)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
por: Kondo, Yumiko, et al.
Publicado: (2022)

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis
por: Bartis, Domokos, et al.
Publicado: (2016)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis
por: Pai, Chen-Hsueh, et al.
Publicado: (2020)

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
por: Satoh, Kimio, et al.
Publicado: (2018)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

CD248 facilitates tumor growth via its cytoplasmic domain
por: Maia, Margarida, et al.
Publicado: (2011)

Interference in melanoma CD248 function reduces vascular mimicry and metastasis
por: Kuo, Cheng-Hsiang, et al.
Publicado: (2022)

Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome
por: Patrick, Kieran, et al.
Publicado: (2023)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension
por: Yao, Xiaoting, et al.
Publicado: (2021)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Abstract 99: Isolation of CD248 Expressing Adipose Derived Stromal Cells for Targeted Improvement of Wound Healing
por: Brett, Elizabeth, et al.
Publicado: (2017)

Transcription factors and potential therapeutic targets for pulmonary hypertension
por: Yang, Liu, et al.
Publicado: (2023)

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension
por: Zeng, Cheng, et al.
Publicado: (2023)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Chen, Lingdan, et al.
Publicado: (2020)

Mechanism of alpha-lipoic acid in attenuating kanamycin-induced ototoxicity☆
por: Wang, Aimei, et al.
Publicado: (2012)

FoxO3a plays a key role in the protective effects of pomegranate peel extract against amikacin-induced ototoxicity
por: Liu, Shuangyue, et al.
Publicado: (2017)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis
por: Naylor, Amy J., et al.
Publicado: (2014)

CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes
por: Matsushima, Sayomi, et al.
Publicado: (2020)

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
por: Rybinski, Katherine, et al.
Publicado: (2015)

Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
por: Xu, Han, et al.
Publicado: (2022)

Diagnostic and therapeutic algorithm for pulmonary arterial hypertension
por: Desai, Ankit A., et al.
Publicado: (2011)

Apelin-APJ Signaling: a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Kim, Jongmin
Publicado: (2014)

BMP type II receptor as a therapeutic target in pulmonary arterial hypertension
por: Orriols, Mar, et al.
Publicado: (2017)

Screening and Identification of Therapeutic Targets for Pulmonary Arterial Hypertension Through Microarray Technology
por: Li, Qing, et al.
Publicado: (2020)

Piezo1, a novel therapeutic target to treat pulmonary arterial hypertension
por: Yang, Qifeng, et al.
Publicado: (2023)

CD39 in the development and progression of pulmonary arterial hypertension
por: Willcox, Abbey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_emn0sq1l66pe1am30i918mv9sk